Physician profile
Yazan Khatib
NPI 1588653257
$16,484.93
in general payments reported to CMS, 2019-2025
58 companies · $1,074 in 2025
The $1,074 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $7,840 · 2020: $1,625 · 2021: $1,766 · 2022: $1,698 · 2023: $1,204 · 2024: $1,278 · 2025: $1,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,556.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $6,400.00 | 2019 | |
| Merit Medical Systems INC | $1,250.00 | 2020-2022 | |
| Abbott Laboratories | $1,160.79 | 2019-2025 | Esprit, Xact, Perclose Prostyle |
| Bard Peripheral Vascular, INC. | $1,108.95 | 2021-2025 | Venovo, Set Aspirex S 10f 110cm, Wavelinq |
| Cook Medical LLC | $632.79 | 2019-2021 | |
| Cvrx, INC. | $505.57 | 2021-2025 | Barostim Neo System |
| Abiomed | $364.40 | 2019-2024 | Impella |
| Pfizer INC. | $356.51 | 2019-2025 | |
| Boston Scientific Corporation | $335.79 | 2020-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $331.22 | 2019-2024 | Xarelto |
| Philips North America LLC | $318.85 | 2019-2024 | (Ck4) Mcot |
| Medtronic, INC. | $259.34 | 2022-2025 | Turbohawk, Abre, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $253.15 | 2020-2025 | |
| Amgen INC. | $250.78 | 2021-2024 | Repatha |
| Venclose INC. | $247.31 | 2020 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.55 | 2020-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $188.78 | 2019-2025 | Camzyos, Eliquis |
| Opsens INC. | $173.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $170.98 | 2019-2024 | |
| Stryker Corporation | $161.48 | 2025 | Limflow System |
| Cardiovascular Systems INC. | $148.91 | 2019 | |
| Medtronic Vascular, INC. | $145.17 | 2019-2020 | |
| Zoll Circulation INC | $131.90 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Inspire Medical Systems, INC. | $114.83 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $106.77 | 2020-2024 | Wainua |
| Terumo Medical Corporation | $90.91 | 2021-2025 | R2p Misago, Tr Band, Glidewire |
| Siemens Medical Solutions USA, INC. | $90.54 | 2022 | |
| Janssen Scientific Affairs, LLC | $84.39 | 2023 | Xarelto |
| Innovation Technologies INC | $73.48 | 2024-2025 | Irrisept |
| Reflow Medical INC | $69.93 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $69.30 | 2022-2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $60.50 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $59.45 | 2020-2022 | |
| Angiodynamics, INC. | $51.01 | 2020 | |
| Veryan Medical Incorporated | $45.28 | 2021 | |
| Esperion Therapeutics, INC. | $44.80 | 2020-2023 | Nexletol |
| Acutus Medical, INC. | $38.79 | 2021-2022 | |
| Asahi Intecc USA, INC. | $31.64 | 2024 | Peripheral Vascular |
| Baxter Healthcare | $30.38 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.17 | 2023 | Lifevest |
| Cordis US Corp. | $24.74 | 2025 | Mynx Control Venous |
| Bayer Healthcare Pharmaceuticals INC. | $24.07 | 2021 | |
| Covidien LP | $22.02 | 2020 | |
| Inspiremd LTD | $21.41 | 2025 | Cguard Prime Carotid Stent System |
| Lexicon Pharmaceuticals, INC. | $21.16 | 2023 | Inpefa |
| Globus Medical, INC. | $19.54 | 2025 | Senza |
| Penumbra, INC. | $19.51 | 2024 | Indigo System |
| Axsome Therapeutics, INC. | $19.23 | 2024 | Sunosi |
| Celgene Corporation | $18.85 | 2025 | Eliquis |
| Endologix LLC | $17.37 | 2023 | Endocross Device, Torus Stent Graft System |
| Irhythm Technologies, INC. | $17.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.88 | 2025 | Evkeeza |
| Imperative Care, INC | $14.50 | 2024 | Symphony Catheter |
| Glaxosmithkline, LLC. | $14.49 | 2025 | Shingrix, Arexvy |
| Bardy Diagnostics, INC. | $12.50 | 2020 | |
| Impulse Dynamics (USA) INC. | $12.24 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,894.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yazan Khatib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.